GlassScriptPhysician profile
Sandra A Edwards
NPI 1609451632
$3,114.25
in general payments reported to CMS, 2019-2025
13 companies · $1,205 in 2025
The $1,205 reported for 2025 was more than what 84% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $273 · 2023: $1,007 · 2024: $630 · 2025: $1,205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,776 · Education: $65.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,775.64 |
| Education | $65.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $770.35 | 2023-2025 | Abilify Maintena, Rexulti, Abilify Asimtufii |
| Alkermes, INC. | $312.57 | 2022-2025 | Aristada, Lybalvi |
| Abbvie INC. | $268.99 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $263.57 | 2023-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $254.42 | 2024-2025 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $251.22 | 2022-2025 | Austedo Xr, Uzedy |
| Boston Scientific Corporation | $212.62 | 2025 | Watchman Access System |
| Janssen Pharmaceuticals, INC | $194.24 | 2024 | Invega Sustenna |
| Supernus Pharmaceuticals, INC. | $124.98 | 2023 | Qelbree |
| Axsome Therapeutics, INC. | $121.83 | 2023 | Auvelity |
| Mdd US Operations, LLC | $119.38 | 2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $114.95 | 2023 | Jornay Pm |
| Corium, LLC | $105.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.